Cargando…

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR

BACKGROUND: Multiple clinical risk factors and genetic profiles have been demonstrated to predict progression of non-muscle invasive bladder cancer; however, no easily clinical applicable gene signature has been developed to predict disease progression independent of disease stage and grade. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dyrskjøt, L, Reinert, T, Novoradovsky, A, Zuiverloon, T C M, Beukers, W, Zwarthoff, E, Malats, N, Real, F X, Segersten, U, Malmström, P-U, Knowles, M, Hurst, C, Sorge, J, Borre, M, Ørntoft, T F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494423/ https://www.ncbi.nlm.nih.gov/pubmed/22976798 http://dx.doi.org/10.1038/bjc.2012.412

Ejemplares similares

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours
por: Vedder, Moniek M., et al.
Publicado: (2014)

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma
por: Dyrskjøt, L, et al.
Publicado: (2012)

Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
por: Reinert, Thomas, et al.
Publicado: (2012)

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2015)

A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene
por: Hurst, Carolyn D, et al.
Publicado: (2009)

Gene expression profiling of noninvasive primary urothelial tumours using microarrays
por: Aaboe, M, et al.
Publicado: (2005)

Selection of Microsatellite Markers for Bladder Cancer Diagnosis without the Need for Corresponding Blood
por: van Tilborg, Angela A. G., et al.
Publicado: (2012)

The Use of Molecular Analyses in Voided Urine for the Assessment of Patients with Hematuria
por: Beukers, Willemien, et al.
Publicado: (2013)

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer
por: Laurberg, Jens Reumert, et al.
Publicado: (2014)

Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder
por: Herbsleb, Malene, et al.
Publicado: (2008)

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2014)

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
por: Egerod, Frederikke Lihme, et al.
Publicado: (2009)

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
por: Teo, M. T. W., et al.
Publicado: (2014)

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer
por: Nordentoft, Iver, et al.
Publicado: (2012)

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
por: Kristensen, Helle, et al.
Publicado: (2016)

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer
por: Villadsen, S B, et al.
Publicado: (2012)

Low ANXA10 expression is associated with disease aggressiveness in bladder cancer
por: Munksgaard, P P, et al.
Publicado: (2011)

The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer
por: Hemdan, T, et al.
Publicado: (2014)

Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts
por: Brems-Eskildsen, Anne Sofie, et al.
Publicado: (2010)

Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients
por: Chan, Owen T.M., et al.
Publicado: (2017)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Universal Reference RNA as a standard for microarray experiments
por: Novoradovskaya, Natalia, et al.
Publicado: (2004)

Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array
por: Tørring, N, et al.
Publicado: (2007)

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
por: Thomsen, Mathilde Borg Houlberg, et al.
Publicado: (2017)

Are microRNAs located in genomic regions associated with cancer?
por: Lamy, P, et al.
Publicado: (2006)

Manual delineation approaches for direct imaging of the subcortex
por: Alkemade, Anneke, et al.
Publicado: (2021)

Delineation of VEGF-regulated genes and functions in the cervix of pregnant rodents by DNA microarray analysis
por: Mowa, Chishimba N, et al.
Publicado: (2008)

Delineation of amplification, hybridization and location effects in microarray data yields better-quality normalization
por: Hulsman, Marc, et al.
Publicado: (2010)

Delineating Novel Signature Patterns of Altered Gene Expression in Schizophrenia Using Gene Microarrays
por: Mirnics, Karoly, et al.
Publicado: (2001)

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?
por: Beukers, Willemien, et al.
Publicado: (2012)

In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: a case report
por: Zuiverloon, Tahlita CM, et al.
Publicado: (2010)

Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes
por: Lurkin, Irene, et al.
Publicado: (2010)

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
por: Lindskrog, Sia Viborg, et al.
Publicado: (2021)

Bioinformatics facilitating the use of microarrays to delineate potential miRNA biomarkers in aristolochic acid nephropathy
por: Lv, Yana, et al.
Publicado: (2016)

Toward spatio‐temporal delineation of positive interactions in ecology
por: Tumolo, Benjamin B., et al.
Publicado: (2020)

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
por: Zieger, Karsten, et al.
Publicado: (2009)

Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer
por: Sørensen, K D, et al.
Publicado: (2013)

Construction and validation of the APOCHIP, a spotted oligo-microarray for the study of beta-cell apoptosis
por: Magnusson, Nils E, et al.
Publicado: (2005)

Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression
por: Leighton, Ximena, et al.
Publicado: (2018)

Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells
por: Herbsleb, Malene, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_kb4rq9cqo6l06ja5a6cugfqasa